Diabetes and Lung Disease: An Underestimated Relationship

Abstract

■ AbstractBACKGROUND: Diabetes mellitus is a systemic disorder associated with inflammation and oxidative stress which may target many organs such as the kidney, retina, and the vascular system. The pathophysiology, mechanisms, and consequences of diabetes on these organs have been studied widely. However, no work has been done on the concept of the lung as a target organ for diabetes and its implications for lung diseases. AIM: In this review, we aimed to investigate the effects of diabetes and hypoglycemic agent on lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis, pulmonary hypertension, and lung cancer. We also reviewed the potential mechanisms by which these effects may affect lung disease patients. RESULTS: Our results suggest that diabetes can affect the severity and clinical course of several lung diseases. CONCLUSIONS: Although the diabetes-lung association is epidemiologically and clinically well-established, especially in asthma, the underlying mechanism and pathophysiology are not been fully understood. Several mechanisms have been suggested, mainly associated with the proinflammatory and proliferative properties of diabetes, but also in relation to micro-and macrovascular effects of diabetes on the pulmonary vasculature. Also, hypoglycemic drugs may influence lung diseases in different ways. For example, metformin was considered a potential therapeutic agent in lung diseases, while insulin was shown to exacerbate lung diseases; this suggests that their effects extend beyond their hypoglycemic properties.Keywords: diabetes · asthma · chronic obstructive pulmonary disease · COPD · idiopathic pulmonary fibrosis · pulmonary hypertension · lung cancer · hypoglycemic drugs

Carbohydrate and Lipid Metabolic Profiles Of Tuberculosis Patients With Bilateral Pulmonary Lesions and Mycobacteria Excretion

“…Studies show that many people with type 2 diabetes also suffer from interstitial lung disease. The pro-inflammatory, proliferative, and oxidative properties of hyperglycemia have been shown to have an important role in affecting pulmonary vasculature, airways, and lung parenchyma [3][4][5]. But inflammatory lung diseases also can be a reason of glucose metabolism disorders.…”

The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation: a correlation analysis

“…On the one hand, the lung parenchyma is gradually destroyed, resulting in the loss of attachment of alveoli and small airways and the reduction of lung elastic retraction, which ultimately leads to emphysema [ 24 ]. On the other hand, long-term hypoxia, chronic inflammation and other factors lead to pulmonary vasoconstriction, pulmonary vascular remodeling, which shows that the proportion of pulmonary small blood vessels in the total area of the lung field also gradually decreases, resulting in pulmonary artery widening and pulmonary hypertension [ 25 , 26 ]. Thus, the early detection on the changes of COPD is essential to the prognosis of patients.…”

A Clinical Model for the Prediction of Acute Exacerbation Risk in Patients with Idiopathic Pulmonary Fibrosis

“…According to the prediction model, DM and EH are high-risk factors for AE-IPF. It is suggested that DM is an independent factor for the occurrence of IPF [ 19 ]. Patients with DM usually experience aberrant lung function, mainly characterized by impairments in lung ventilation, malfunctions in lung diffusion, and abnormalities of bronchomuscular tension and respiratory muscle function [ 20 ].…”